Mortality following acute medical admission in Denmark: A feasibility study

Clinical Epidemiology

Volumn 2, Issue 1, 2010, Pages 195-203

  Schmidt, Morten ^a   Antonsen, Sussie ^a   Hansen, Betina ^a   Møller, Jens ^a   Thordal, Carsten ^a   Sørensen, Henrik Toft ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cohort study; Comorbidity; Epidemiology; Hospital admission; Internal medicine; Prognosis; Registries

Indexed keywords

ADULT; AGE; AGED; ARTICLE; COMORBIDITY; CONFIDENCE INTERVAL; DENMARK; FEASIBILITY STUDY; FEMALE; GENDER; HAZARD RATIO; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; REGISTER; UNIVERSITY HOSPITAL;

EID: 77957125660     PISSN: None     EISSN: 11791349     Source Type: Book Series    
DOI: 10.2147/CLEP.S12171     Document Type: Article

References (19)

1. Gavrilov LA, Heuveline P. Aging of population. In: Demeny P, McNicoll G, editors. The Encyclopedia of Population. New York: Macmillan Reference USA; 2003.
2. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162(20):2269-2276.
3. Statistics Denmark. www.dst.dk
4. Hoffman C, Rice D, Sung HY. Persons with chronic conditions. Their prevalence and costs. JAMA. 1996;276(18):1473-1479.
5. Vaartjes I, de Borst GJ, Reitsma JB, et al. Long-term survival after initial hospital admission for peripheral arterial disease in the lower extremities. BMC Cardiovasc Disord. 2009;9:43.
6. Frank L. Epidemiology. When an entire country is a cohort. Science. 2000;287(5462):2398-2399.
7. Andersen TF, Madsen M, Jorgensen J, Mellemkjaer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46(3):263-268.
8. Pedersen CB, Gøtzsche H, Møller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 2006;53(4):441-449.
9. Sørensen HT, Christensen S, Mehnert F, et al. Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study. BMJ. 2008;336(7648):813-816.
10. Charlson ME, Pompei P, Ales Kl, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
11. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol. 2003;56(3):221-229.
12. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
13. D'Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol. 1996;49(12):1429-1433.
14. Taha AS, McCloskey C, Prasad R, Bezlyak V. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking lowdose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial. Lancet. 2009;374(9684):119-125.
15. Nieto FJ, Coresh J. Adjusting survival curves for confounders: a review and a new method. Am J Epidemiol. 1996;143(10):1059-1068.
16. Sørensen HT. Regional administrative health registers as a resource in clinical epidemiology. A study of options, strengths, limitations and data quality provided with examples of use. Int J Risk Safety Med. 1997;10:1-22.
17. Weiss NS. Clinical epidemiology. In: Rothman KJ, Greenland S, Lash TL, editors. Modern Epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2008:642-646.
18. Christiansen JU, Maruard CD, Nielsen HC. LABKA. A real-time computer system for the clinical laboratory. Scand J Clin Lab Invest Suppl. 1989;194:57-61.
19. Gaist D, Andersen M, Aarup Al, Hallas J, Gram LF. Use of sumatriptan in Denmark in 1994-5: an epidemiological analysis of nationwide prescription data. Br J Clin Pharmacol. 1997;43(4):429-433.